These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31455999)

  • 41. The dominant-STN phenomenon in bilateral STN DBS for Parkinson's disease.
    Castrioto A; Meaney C; Hamani C; Mazzella F; Poon YY; Lozano AM; Hodaie M; Moro E
    Neurobiol Dis; 2011 Jan; 41(1):131-7. PubMed ID: 20826212
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of deep brain stimulation of dorsal versus ventral subthalamic nucleus regions on gait and balance in Parkinson's disease.
    McNeely ME; Hershey T; Campbell MC; Tabbal SD; Karimi M; Hartlein JM; Lugar HM; Revilla FJ; Perlmutter JS; Earhart GM
    J Neurol Neurosurg Psychiatry; 2011 Nov; 82(11):1250-5. PubMed ID: 21478202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Staged bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
    Tanei T; Kajita Y; Kaneoke Y; Takebayashi S; Nakatsubo D; Wakabayashi T
    Acta Neurochir (Wien); 2009 Jun; 151(6):589-94. PubMed ID: 19381434
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The human subthalamic nucleus transiently inhibits active attentional processes.
    Soh C; Hervault M; Chalkley NH; Moore CM; Rohl A; Zhang Q; Uc EY; Greenlee JDW; Wessel JR
    Brain; 2024 Sep; 147(9):3204-3215. PubMed ID: 38436939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parkinsonian Beta Dynamics during Rest and Movement in the Dorsal Pallidum and Subthalamic Nucleus.
    Eisinger RS; Cagle JN; Opri E; Alcantara J; Cernera S; Foote KD; Okun MS; Gunduz A
    J Neurosci; 2020 Apr; 40(14):2859-2867. PubMed ID: 32107277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic deep brain stimulation disrupts movement-related subthalamic nucleus activity in parkinsonian mice.
    Schor JS; Gonzalez Montalvo I; Spratt PWE; Brakaj RJ; Stansil JA; Twedell EL; Bender KJ; Nelson AB
    Elife; 2022 Jul; 11():. PubMed ID: 35786442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subthalamic deep brain stimulation effects on odor identification in Parkinson's disease.
    Fabbri M; Guedes LC; Coelho M; Simão D; Abreu D; Rosa MM; Silveira-Moriyama L; Ferreira JJ
    Eur J Neurol; 2015 Jan; 22(1):207-10. PubMed ID: 24602222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effective network of deep brain stimulation of subthalamic nucleus with bimodal positron emission tomography/functional magnetic resonance imaging in Parkinson's disease.
    Chen HM; Sha ZQ; Ma HZ; He Y; Feng T
    CNS Neurosci Ther; 2018 Feb; 24(2):135-143. PubMed ID: 29222835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A causal role for the human subthalamic nucleus in non-selective cortico-motor inhibition.
    Wessel JR; Diesburg DA; Chalkley NH; Greenlee JDW
    Curr Biol; 2022 Sep; 32(17):3785-3791.e3. PubMed ID: 35841891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improving outcomes of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Bari AA; Fasano A; Munhoz RP; Lozano AM
    Expert Rev Neurother; 2015 Oct; 15(10):1151-60. PubMed ID: 26377740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Weight change after globus pallidus internus or subthalamic nucleus deep brain stimulation in Parkinson's disease and dystonia.
    Mills KA; Scherzer R; Starr PA; Ostrem JL
    Stereotact Funct Neurosurg; 2012; 90(6):386-93. PubMed ID: 22922491
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improvement of memory guided saccades in parkinsonian patients by high frequency subthalamic nucleus stimulation.
    Rivaud-Péchoux S; Vermersch AI; Gaymard B; Ploner CJ; Bejjani BP; Damier P; Demeret S; Agid Y; Pierrot-Deseilligny C
    J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):381-4. PubMed ID: 10675227
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of specific components of sleep disturbances by simultaneous subthalamic and nigral stimulation in Parkinson's disease.
    Hidding U; Gulberti A; Pflug C; Choe C; Horn A; Prilop L; Braaß H; Fründt O; Buhmann C; Weiss D; Westphal M; Engel AK; Gerloff C; Köppen JA; Hamel W; Moll CKE; Pötter-Nerger M
    Parkinsonism Relat Disord; 2019 May; 62():141-147. PubMed ID: 30616868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson's disease.
    Wolz M; Hauschild J; Koy J; Fauser M; Klingelhöfer L; Schackert G; Reichmann H; Storch A
    Parkinsonism Relat Disord; 2012 Sep; 18(8):994-7. PubMed ID: 22682974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of subthalamic deep brain stimulation on turning kinematics and related saccadic eye movements in Parkinson disease.
    Lohnes CA; Earhart GM
    Exp Neurol; 2012 Aug; 236(2):389-94. PubMed ID: 22580213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SPECT and PET analysis of subthalamic stimulation in Parkinson's disease: analysis using a manual segmentation.
    Haegelen C; García-Lorenzo D; Le Jeune F; Péron J; Gibaud B; Riffaud L; Brassier G; Barillot C; Vérin M; Morandi X
    J Neurol; 2010 Mar; 257(3):375-82. PubMed ID: 19774437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease on Associative Learning of Verbal and Non-Verbal Information by Trial and Error or with Corrective Feedback.
    Leimbach F; Atkinson-Clement C; Socorro P; Jahanshahi M
    J Parkinsons Dis; 2022; 12(3):885-896. PubMed ID: 35342046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subthalamic nucleus stimulation increases brain derived neurotrophic factor in the nigrostriatal system and primary motor cortex.
    Spieles-Engemann AL; Steece-Collier K; Behbehani MM; Collier TJ; Wohlgenant SL; Kemp CJ; Cole-Strauss A; Levine ND; Gombash SE; Thompson VB; Lipton JW; Sortwell CE
    J Parkinsons Dis; 2011; 1(1):123-36. PubMed ID: 22328911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sensorimotor subthalamic stimulation restores risk-reward trade-off in Parkinson's disease.
    Irmen F; Horn A; Meder D; Neumann WJ; Plettig P; Schneider GH; Siebner HR; Kühn AA
    Mov Disord; 2019 Mar; 34(3):366-376. PubMed ID: 30485537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.